Treatment of Tinea Corporis
The first-line treatment for tinea corporis is topical terbinafine 1% cream applied once daily for 1-2 weeks, which offers faster clinical resolution than other topical agents with mycological cure rates of 84.2% compared to 23.3% for placebo. 1
Diagnosis Confirmation
- Accurate diagnosis is essential before initiating treatment
- Confirm diagnosis through:
Treatment Algorithm
1. Localized Tinea Corporis (First-Line)
- Topical antifungal agents:
- Terbinafine 1% cream: Apply once daily for 1-2 weeks 1, 3
- Clotrimazole 1% cream: Apply twice daily for 2-4 weeks 1, 4
- Miconazole 2% cream: Apply twice daily for 2-4 weeks 1
- Ciclopirox olamine 0.77% cream/gel: Apply twice daily for 4 weeks (clinical and mycological cure rates ~60% at end of treatment) 1
2. Extensive or Resistant Tinea Corporis (Second-Line)
- Oral antifungal agents:
- Terbinafine: 250 mg once daily for 1-2 weeks (especially effective for Trichophyton species) 1
- Itraconazole: 100 mg once daily for 2 weeks (87% mycological cure rate) 1
- Griseofulvin:
- Adults: 0.5 g daily (125 mg four times a day, 250 mg twice a day, or 500 mg once daily)
- Children (>2 years): 10 mg/kg daily for 2-4 weeks 2
- Fluconazole: 150 mg once weekly for 2-4 weeks 5, 6
Duration of Treatment
- Continue treatment for at least one week after clinical resolution 1, 7
- Treatment endpoint should be mycological cure, not just clinical improvement 1
- For tinea corporis, typical treatment duration is:
Prevention and Hygiene Measures
- Apply antifungal powders containing miconazole or clotrimazole to prevent reinfection 1
- Avoid sharing towels and personal items 1
- Examine and treat all household members for anthropophilic infections 1
Follow-up Recommendations
- Clinical improvement typically expected within 1-2 weeks 1
- Return for follow-up if symptoms persist or recur within 2 months 1
- Consider follow-up mycological examination in resistant or recurrent cases 1
Important Considerations
- Topical therapy is preferred for localized infection, while oral therapy is reserved for extensive, resistant, or multiple-site infections 1, 6
- Unnecessary or inappropriate use of OTC preparations can delay proper treatment 1
- The presence of inflammation may necessitate the use of an agent with inherent anti-inflammatory properties, but combination antifungal/steroid agents should be used with caution due to potential for causing atrophy 7
- Oral antifungals may have side effects including gastrointestinal disturbances, rashes, and rarely more serious adverse reactions like Stevens-Johnson syndrome and hepatic toxicity 1